Skene's gland adenocarcinoma with increased serum level of prostate- specific antigen

M. K. Dodson, William Arthur Cliby, Gary Keeney, M. F. Peterson, K. C. Podratz

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Skene's (periurethral) gland carcinoma is a rare neoplasm accounting for less than 0.003% of all genital tract malignancies in females. Generally, adenocarcinomas of the female urethra are assumed to arise from the periurethral glands, the female homologue of the prostate. A case of Skene's gland adenocarcinoma without mucosal urethral involvement is presented. The histologic features of this tumor closely resembled those of prostatic adenocarcinoma. In contrast, clear cell and columnar/mucinous variants of female urethral adenocarcinomas have been described previously. Perhaps this signifies different biologic processes in the development of Skene's/periurethral and urethral adenocarcinomas in females. Additionally, we performed immunohistochemical staining that was reactive for prostate- specific antigen (PSA). Preoperatively, the serum level of PSA was increased and promptly decreased after surgical excision of the lesion. Therefore, preoperative and postoperative monitoring of serum PSA titers in patients with adenocarcinomas of the female urethra or periurethral glands (or both) should be considered.

Original languageEnglish (US)
Pages (from-to)304-307
Number of pages4
JournalGynecologic Oncology
Volume55
Issue number2
DOIs
StatePublished - 1994

Fingerprint

Prostate-Specific Antigen
Adenocarcinoma
Serum
Urethra
Neoplasms
Prostate
Staining and Labeling
Carcinoma

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Skene's gland adenocarcinoma with increased serum level of prostate- specific antigen. / Dodson, M. K.; Cliby, William Arthur; Keeney, Gary; Peterson, M. F.; Podratz, K. C.

In: Gynecologic Oncology, Vol. 55, No. 2, 1994, p. 304-307.

Research output: Contribution to journalArticle

@article{b48b56283fba421aaac75a8fec24f339,
title = "Skene's gland adenocarcinoma with increased serum level of prostate- specific antigen",
abstract = "Skene's (periurethral) gland carcinoma is a rare neoplasm accounting for less than 0.003{\%} of all genital tract malignancies in females. Generally, adenocarcinomas of the female urethra are assumed to arise from the periurethral glands, the female homologue of the prostate. A case of Skene's gland adenocarcinoma without mucosal urethral involvement is presented. The histologic features of this tumor closely resembled those of prostatic adenocarcinoma. In contrast, clear cell and columnar/mucinous variants of female urethral adenocarcinomas have been described previously. Perhaps this signifies different biologic processes in the development of Skene's/periurethral and urethral adenocarcinomas in females. Additionally, we performed immunohistochemical staining that was reactive for prostate- specific antigen (PSA). Preoperatively, the serum level of PSA was increased and promptly decreased after surgical excision of the lesion. Therefore, preoperative and postoperative monitoring of serum PSA titers in patients with adenocarcinomas of the female urethra or periurethral glands (or both) should be considered.",
author = "Dodson, {M. K.} and Cliby, {William Arthur} and Gary Keeney and Peterson, {M. F.} and Podratz, {K. C.}",
year = "1994",
doi = "10.1006/gyno.1994.1294",
language = "English (US)",
volume = "55",
pages = "304--307",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Skene's gland adenocarcinoma with increased serum level of prostate- specific antigen

AU - Dodson, M. K.

AU - Cliby, William Arthur

AU - Keeney, Gary

AU - Peterson, M. F.

AU - Podratz, K. C.

PY - 1994

Y1 - 1994

N2 - Skene's (periurethral) gland carcinoma is a rare neoplasm accounting for less than 0.003% of all genital tract malignancies in females. Generally, adenocarcinomas of the female urethra are assumed to arise from the periurethral glands, the female homologue of the prostate. A case of Skene's gland adenocarcinoma without mucosal urethral involvement is presented. The histologic features of this tumor closely resembled those of prostatic adenocarcinoma. In contrast, clear cell and columnar/mucinous variants of female urethral adenocarcinomas have been described previously. Perhaps this signifies different biologic processes in the development of Skene's/periurethral and urethral adenocarcinomas in females. Additionally, we performed immunohistochemical staining that was reactive for prostate- specific antigen (PSA). Preoperatively, the serum level of PSA was increased and promptly decreased after surgical excision of the lesion. Therefore, preoperative and postoperative monitoring of serum PSA titers in patients with adenocarcinomas of the female urethra or periurethral glands (or both) should be considered.

AB - Skene's (periurethral) gland carcinoma is a rare neoplasm accounting for less than 0.003% of all genital tract malignancies in females. Generally, adenocarcinomas of the female urethra are assumed to arise from the periurethral glands, the female homologue of the prostate. A case of Skene's gland adenocarcinoma without mucosal urethral involvement is presented. The histologic features of this tumor closely resembled those of prostatic adenocarcinoma. In contrast, clear cell and columnar/mucinous variants of female urethral adenocarcinomas have been described previously. Perhaps this signifies different biologic processes in the development of Skene's/periurethral and urethral adenocarcinomas in females. Additionally, we performed immunohistochemical staining that was reactive for prostate- specific antigen (PSA). Preoperatively, the serum level of PSA was increased and promptly decreased after surgical excision of the lesion. Therefore, preoperative and postoperative monitoring of serum PSA titers in patients with adenocarcinomas of the female urethra or periurethral glands (or both) should be considered.

UR - http://www.scopus.com/inward/record.url?scp=0027946088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027946088&partnerID=8YFLogxK

U2 - 10.1006/gyno.1994.1294

DO - 10.1006/gyno.1994.1294

M3 - Article

C2 - 7525428

AN - SCOPUS:0027946088

VL - 55

SP - 304

EP - 307

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -